Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
microstad húðuð tafla 150 míkróg/30 míkróg
stada arzneimittel ag - levonorgestrelum inn; ethinylestradiolum inn - húðuð tafla - 150 míkróg/30 míkróg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
revastad filmuhúðuð tafla 20 mg
stada arzneimittel ag - sildenafilum cítrat - filmuhúðuð tafla - 20 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
spiolto respimat innöndunarlausn 2,5/2,5 míkróg
boehringer ingelheim international gmbh* - tiotropii bromidum inn; olodaterolum hýdróklóríð - innöndunarlausn - 2,5/2,5 míkróg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
tamsulosin medical (tamsulijn) hart hylki með breyttan losunarhraða 0,4 mg
medical ehf. - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic lyfjum - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.